Clinical Research Directory

Inclusion Criteria: 1. Male or female aged 18-90 2. The patient is diagnosed with lower extremity peripheral arterial disease 3. The patient is willing to comply with specified follow-up evaluations at the specified times 4. The patient understands the nature of the procedure and provides written informed consent before enrolment in the study 5. Before enrolment, the guidewire has crossed the target lesion 6. No restrictions on Rutherford grading, TASC grading, GLASS grading Exclusion Criteria: 1. Pregnant women or Female patients with potential childbearing 2. The patient is currently participating in another investigational drug or device study that has not reached the primary endpoint. 3. Patients unwilling or refusing to sign informed consent 4. Patients with other diseases that may seriously affect the quality of life, such as tumors, severe liver disease, cardiac insufficiency, etc., or those with a life expectancy of less than 2 years